Skip to main content

Anxious Surveillance: Coping with Anxiety and Active Surveillance
January 29, 2022 @ 12:00 pm EDT

To Learn More Click Here

View our Meeting Videos

Meeting Videos

ASPI – A Place for Options 

All of us have experienced the anxiety and uncertainty you may now feel. Should I have treatment or can I wait or avoid treatment all together? How do I know what “low risk” is, and how do I determine if I’m low risk? What is Active Surveillance?

ASPI’s Board’s goal is to offer you informed options – empowering you if you should choose to immerse yourself in what we offer. Our board has many years of Active Surveillance experience and has an international support network to equip men with the knowledge they will need to discuss their choice of care with their clinician. We’ve worked with the challenges and questions you now face. Also, the decision to transition from AS to treatment can be stressful. Two of our board members have made that journey, and we can offer support in that process as well.

We have found a kind of peaceful vigilance in our journey, and you can arrive there as well. Please read our mission statement, newsletters, patient stories, blogs, webinars, watch meeting videos, late-breaking news, ever-changing protocols – and much more.

Finally, get in touch with us at and we’ll be sure to get back to you.

And one additional request: should you find our information worthwhile and you become involved with our organization in helping other men, your financial participation – in the form of any amount – will further support our mission and would be welcome.
Click here to support us: Thank you.


Headshot of AS Patient Thrainn Thorvaldsson
Thrainn’s Story

In my opinion, my greatest personal accomplishment was to undertake extensive research on my own, followed by choosing AS. When I was diagnosed with PC at the age of 61, my doctors strongly recommended that I undergo traditional treatment. Surgery was at the top of the list.

Headshot of AS Patient Mark Lichty
Mark's Story

Sixteen years ago, I was diagnosed with Gleason 6 prostate cancer at the age of 55 – and, against the advice of five medical professionals (including my wife, a nurse practitioner) I chose not to have intervention.

Years on Active Surveillance

Patients Years Months
Mark Lichty 16 6
Philip Segal 14 9
Bill Manning 12 2
Howard Wolinsky 10 6
Geoff McLennan 9 8
David King Keller 7 6
Martin Gewirtz 4 2

The following ASPI directors have now entered treatment:

Thrainn Torvaldsson after 14 years of A.S.

Joe Gallo after 3 years of A.S.

Articles and Resources